美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Gyre Therapeutics

8.00

-0.0691-0.86%

成交量：1.42萬

成交額：11.48萬

市值：7.68億

市盈率：166.42

高：8.14

開：8.09

低：8.00

收：8.07

資料載入中...

總覽公司新聞公告

BUZZ--美國股票走勢-Oklo、鈾股、工作日

Gyre Therapeutics, Inc.盤中異動早盤急速跳水6.78%

BUZZ--美國股票走勢-特斯拉、黃金礦工、Intuit

BUZZ-Gyre Therapeutics 股票募集後暴跌

BUZZ-Gyre Therapeutics 股票發行後暴跌

Gyre Therapeutics, Inc.盤中異動下午盤快速下跌5.26%

Gyre Therapeutics, Inc.盤中異動早盤大幅拉昇5.03%

Gyre Therapeutics, Inc.盤中異動臨近收盤大幅上漲5.00%報10.91美元

Gyre Therapeutics, Inc.盤中異動早盤股價大跌5.04%

Gyre Therapeutics, Inc.盤中異動下午盤股價大漲5.37%

Gyre Therapeutics Inc 預計每股收益3美分 - 財報前瞻

Gyre Therapeutics, Inc.盤中異動股價大漲5.65%

Gyre Therapeutics, Inc.盤中異動早盤快速上漲5.41%

Gyre Therapeutics, Inc.盤中異動股價大跌5.24%報7.96美元

Gyre Therapeutics, Inc.盤中異動大幅跳水5.00%

Gyre Therapeutics, Inc.盤中異動急速下挫7.45%報6.70美元

Gyre Therapeutics, Inc.盤中異動股價大跌6.01%報6.50美元

Gyre Therapeutics, Inc.盤中異動早盤大幅下挫5.15%

Gyre Therapeutics, Inc.盤中異動早盤快速下跌6.77%報6.61美元

Gyre Therapeutics, Inc.2024財年實現淨利潤12.09百萬美元，同比增加113.01%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/GYRE/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GYRE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GYRE\",,,,,undefined,":{"symbol":"GYRE","market":"US","secType":"STK","nameCN":"Gyre Therapeutics","latestPrice":8.0009,"timestamp":1750687328635,"preClose":8.07,"halted":0,"volume":14217,"delay":0,"floatShares":25607700,"shares":95979800,"eps":0.048077,"marketStatus":"交易中","change":-0.0691,"latestTime":"06-23 10:02:12 EDT","open":8.09,"high":8.137,"low":8,"amount":114836.60905500001,"amplitude":0.016976,"askPrice":8.07,"askSize":143,"bidPrice":8.01,"bidSize":6,"shortable":3,"etf":0,"ttmEps":0.048077,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1750708800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":8.07,"preHourTrading":{"tag":"盘前","latestPrice":8.15,"preClose":8.07,"latestTime":"08:00 EDT","volume":25,"amount":203.75,"timestamp":1750680002520},"postHourTrading":{"tag":"盘后","latestPrice":8.07,"preClose":8.07,"latestTime":"17:39 EDT","volume":14612,"amount":117918.84,"timestamp":1750455559525},"volumeRatio":1.235749,"impliedVol":0.7234,"impliedVolPercentile":0.6667},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GYRE\",,,,,undefined,":{"symbol":"GYRE","floatShares":25607700,"roa":"5.18%","roe":"12.12%","lyrEps":0.142017,"volumeRatio":1.235749,"shares":95979800,"dividePrice":0,"high":8.137,"amplitude":0.016976,"preClose":8.07,"low":8,"week52Low":6.11,"pbRate":"11.27","psRate":"7.63","week52High":19,"institutionHeld":0.0832,"latestPrice":8.0009,"committee":-0.919463,"eps":0.048077,"divideRate":0,"volume":14217,"delay":0,"ttmEps":0.048077,"open":8.09,"prevYearClose":12.1,"prevWeekClose":8.07,"prevMonthClose":9.07,"prevQuarterClose":7.72,"fiveDayClose":7.99,"twentyDayClose":11.21,"sixtyDayClose":8.79},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GYRE\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2537645153","title":"BUZZ--美國股票走勢-Oklo、鈾股、工作日","url":"https://stock-news.laohu8.com/highlight/detail?id=2537645153","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537645153?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 23:58","pubTimestamp":1748015917,"startTime":"0","endTime":"0","summary":".N 美国东部时间11:30，道琼斯工业平均指数.DJI下跌0.65%，报41587.30点。标普500指数.SPX下跌0.77%，报5797.10点；纳斯达克综合指数.IXIC下跌1.02%，报18732.06点。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nL4S3RV12J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DECK","ENPH","IMNN","IE00B4YYXB79.USD","FLR","BLMZ","GDHG","CPRT","MACW.SI","ROST","FSLR","LU1316542783.SGD","LU1935043536.SGD","LU2023250843.SGD","INTU","09896","AAP","LU2249611893.SGD","NTCL","LU0266512127.USD","WDAY","BK4099","IE0004445015.USD","OKLO","BCAX","APO","SCHW","DOUG","LU1429558221.USD","LU2237438978.USD","CEG","GRDN","LU0053666078.USD","NEM","LU0203201768.USD","BK4023","BK4182","IVZ","PMAX","LU0477156797.USD","BAH","BAC","GYRE","TSYW.SI","HNRG","KKR"],"gpt_icon":1},{"id":"2537329481","title":"Gyre Therapeutics, Inc.盤中異動 早盤急速跳水6.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537329481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537329481?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 21:32","pubTimestamp":1748007144,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日21时32分，Gyre Therapeutics, Inc.股票出现异动，股价急速下挫6.78%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.82%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家商业阶段的制药公司，开发和商业化针对器官疾病的小分子抗炎和抗纤维化药物，特别关注器官纤维化。该公司的可报告部门是 Gyre Pharmaceuticals，该公司从在中国销售 艾思瑞和某些仿制药、Gyre 和其他部门获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523213225a6ea5e33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523213225a6ea5e33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GYRE","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2537135920","title":"BUZZ--美國股票走勢-特斯拉、黃金礦工、Intuit","url":"https://stock-news.laohu8.com/highlight/detail?id=2537135920","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537135920?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 19:43","pubTimestamp":1748000619,"startTime":"0","endTime":"0","summary":".N** Deckers Outdoor Corp < DECK.N  >:BUZZ - 在取消年度预测后下跌   nL6N3RV0ES ** 特斯拉公司 < TSLA.O  >:BUZZ - Wedbush 看好特斯拉的 \"自主黄金时代\"，上调预期价格。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"332dcb330d18c7bb046746bd4220a0db","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nL4T3RV0RR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443622.USD","LU1084165304.USD","IE00BKVL7J92.USD","LU1023059493.AUD","LU1894683264.USD","LU1043141396.HKD","LU0323591593.USD","LU0345770993.USD","LU1429558221.USD","IE00BFXG1179.USD","LU0234572021.USD","TSYW.SI","BK4570","LU1223082196.USD","LU2106854487.HKD","LU0738911758.USD","LU2089283258.USD","ROST","DECK","LU1852331112.SGD","LU2265009873.SGD","LU1244550494.USD","NEM","LU2552382215.SGD","IE0034235295.USD","LU1223082519.USD","LU0345780521.USD","IE00B1XK9C88.USD","LU2750360997.AUD","LU0077335932.USD","LU0345780281.USD","CPRT","LU1629891620.HKD","LU2023251221.USD","LU0353189680.USD","LU1861220033.SGD","LU2237443549.SGD","LU1670628061.USD","TSLA","IE00BK4W5M84.HKD","IE00B1BXHZ80.USD","IE00B3S45H60.SGD","BK4543","LU1894683348.USD","GYRE","LU0316494557.USD","LU1435385759.SGD","BK4533","INTU","LU1280957306.USD"],"gpt_icon":1},{"id":"2537817138","title":"BUZZ-Gyre Therapeutics 股票募集後暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2537817138","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537817138?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 18:36","pubTimestamp":1747996609,"startTime":"0","endTime":"0","summary":"BUZZ-Gyre Therapeutics 股票募集后暴跌5月23日 - ** Gyre Therapeutics GYRE.O在后续定价后，股价在收盘前下跌 15.3%，至 9.50 美元。** 杰富瑞是此次发行的簿记管理人** 周四晚些时候，该公司称  其主要化合物 Hydronidone、 在评估治疗中国慢性乙型肝炎患者肝纤维化的有效性和安全性的关键性 III 期试验中达到了主要终点。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nL4T3RV0OM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GYRE","BK4127","JEF","BK4559"],"gpt_icon":0},{"id":"2537927835","title":"BUZZ-Gyre Therapeutics 股票發行後暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2537927835","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537927835?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 04:37","pubTimestamp":1747946271,"startTime":"0","endTime":"0","summary":"BUZZ-Gyre Therapeutics 股票发行后暴跌5月22日 - ** Gyre Therapeutics GYRE.O股价盘后下跌17.5%，至9.25美元，该公司正寻求股票融资 ** 总部位于圣地亚哥的生物技术公司开始发行股票 ；交易规模未披露** 该公司打算将募集资金净额用于推进 F351 治疗代谢障碍的第二阶段试验。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nL4S3RU1KS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","JEF","BK4127","BK4139","GYRE"],"gpt_icon":0},{"id":"2537132958","title":"Gyre Therapeutics, Inc.盤中異動 下午盤快速下跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537132958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537132958?lang=zh_tw&edition=fundamental","pubTime":"2025-05-22 01:22","pubTimestamp":1747848136,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日01时22分，Gyre Therapeutics, Inc.股票出现异动，股价急速下挫5.26%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.07%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家商业阶段的制药公司，开发和商业化针对器官疾病的小分子抗炎和抗纤维化药物，特别关注器官纤维化。该公司的可报告部门是 Gyre Pharmaceuticals，该公司从在中国销售 艾思瑞和某些仿制药、Gyre 和其他部门获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522012216aa2c95be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522012216aa2c95be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2535203315","title":"Gyre Therapeutics, Inc.盤中異動 早盤大幅拉昇5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535203315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535203315?lang=zh_tw&edition=fundamental","pubTime":"2025-05-16 21:54","pubTimestamp":1747403696,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时54分，Gyre Therapeutics, Inc.股票出现波动，股价大幅拉升5.03%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家商业阶段的制药公司，开发和商业化针对器官疾病的小分子抗炎和抗纤维化药物，特别关注器官纤维化。该公司的可报告部门是 Gyre Pharmaceuticals，该公司从在中国销售 艾思瑞和某些仿制药、Gyre 和其他部门获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516215456975bdd27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516215456975bdd27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","GYRE","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2535487726","title":"Gyre Therapeutics, Inc.盤中異動 臨近收盤大幅上漲5.00%報10.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535487726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535487726?lang=zh_tw&edition=fundamental","pubTime":"2025-05-16 03:58","pubTimestamp":1747339103,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日03时58分，Gyre Therapeutics, Inc.股票出现异动，股价快速上涨5.00%。截至发稿，该股报10.91美元/股，成交量3.6471万股，换手率0.04%，振幅4.72%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.27%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家商业阶段的制药公司，开发和商业化针对器官疾病的小分子抗炎和抗纤维化药物，特别关注器官纤维化。该公司的可报告部门是 Gyre Pharmaceuticals，该公司从在中国销售 艾思瑞和某些仿制药、Gyre 和其他部门获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516035823a6e0bb22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516035823a6e0bb22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GYRE","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2535107372","title":"Gyre Therapeutics, Inc.盤中異動 早盤股價大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535107372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535107372?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 22:13","pubTimestamp":1747231981,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日22时13分，Gyre Therapeutics, Inc.股票出现异动，股价大幅跳水5.04%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家商业阶段的制药公司，开发和商业化针对器官疾病的小分子抗炎和抗纤维化药物，特别关注器官纤维化。该公司的可报告部门是 Gyre Pharmaceuticals，该公司从在中国销售 艾思瑞和某些仿制药、Gyre 和其他部门获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514221302a6df12ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514221302a6df12ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","GYRE","BK4139","BK4007"],"gpt_icon":0},{"id":"2534154405","title":"Gyre Therapeutics, Inc.盤中異動 下午盤股價大漲5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534154405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534154405?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 01:23","pubTimestamp":1746724996,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日01时23分，Gyre Therapeutics, Inc.股票出现波动，股价快速上涨5.37%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.08%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家商业阶段的制药公司，开发和商业化针对器官疾病的小分子抗炎和抗纤维化药物，特别关注器官纤维化。该公司的可报告部门是 Gyre Pharmaceuticals，该公司从在中国销售 艾思瑞和某些仿制药、Gyre 和其他部门获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509012317aa2c882a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509012317aa2c882a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","GYRE","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2533884685","title":"Gyre Therapeutics Inc 預計每股收益3美分 - 財報前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2533884685","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533884685?lang=zh_tw&edition=fundamental","pubTime":"2025-05-05 19:17","pubTimestamp":1746443827,"startTime":"0","endTime":"0","summary":"Gyre Therapeutics Inc 预计每股收益3美分 - 财报前瞻Gyre Therapeutics Inc GYRE.OQ GYRE.O预计将于5月7日公布截至2025年3月31日的业绩(，预计)。LSEG 分析师对 Gyre Therapeutics Inc 的平均预期为每股收益 3 美分。华尔街对 Gyre Therapeutics Inc 的 12 个月目标价中位数为 20.00 美元，高于其上次收盘价 9.26 美元。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL4S3RD0JZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GYRE"],"gpt_icon":0},{"id":"2529532928","title":"Gyre Therapeutics, Inc.盤中異動 股價大漲5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529532928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529532928?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 00:26","pubTimestamp":1745339167,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日00时26分，Gyre Therapeutics, Inc.股票出现波动，股价大幅拉升5.65%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.01%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家商业阶段的制药公司，开发和商业化针对器官疾病的小分子抗炎和抗纤维化药物，特别关注器官纤维化。该公司的可报告部门是 Gyre Pharmaceuticals，该公司从在中国销售 艾思瑞和某些仿制药、Gyre 和其他部门获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423002607a6c402c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423002607a6c402c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GYRE","BK4139","BK4007"],"gpt_icon":0},{"id":"2529802369","title":"Gyre Therapeutics, Inc.盤中異動 早盤快速上漲5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529802369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529802369?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 21:44","pubTimestamp":1745243093,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时44分，Gyre Therapeutics, Inc.股票出现异动，股价快速拉升5.41%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家商业阶段的制药公司，开发和商业化针对器官疾病的小分子抗炎和抗纤维化药物，特别关注器官纤维化。该公司的可报告部门是 Gyre Pharmaceuticals，该公司从在中国销售 艾思瑞和某些仿制药、Gyre 和其他部门获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421214453a6c2743f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421214453a6c2743f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GYRE","BK4007","BK4139"],"gpt_icon":0},{"id":"2528278970","title":"Gyre Therapeutics, Inc.盤中異動 股價大跌5.24%報7.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528278970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528278970?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 01:40","pubTimestamp":1744825224,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日01时40分，Gyre Therapeutics, Inc.股票出现波动，股价快速跳水5.24%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.32%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家商业阶段的制药公司，开发和商业化针对器官疾病的小分子抗炎和抗纤维化药物，特别关注器官纤维化。该公司的可报告部门是 Gyre Pharmaceuticals，该公司从在中国销售 艾思瑞和某些仿制药、Gyre 和其他部门获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417014024aa2c71e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417014024aa2c71e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2526460593","title":"Gyre Therapeutics, Inc.盤中異動 大幅跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526460593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526460593?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 21:31","pubTimestamp":1744291898,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日21时31分，Gyre Therapeutics, Inc.股票出现波动，股价急速跳水5.00%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家商业阶段的制药公司，开发和商业化针对器官疾病的小分子抗炎和抗纤维化药物，特别关注器官纤维化。该公司的可报告部门是 Gyre Pharmaceuticals，该公司从在中国销售 艾思瑞和某些仿制药、Gyre 和其他部门获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041021313894d1e257&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041021313894d1e257&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GYRE","BK4007"],"gpt_icon":0},{"id":"2526395377","title":"Gyre Therapeutics, Inc.盤中異動 急速下挫7.45%報6.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526395377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526395377?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 21:31","pubTimestamp":1744205504,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日21时31分，Gyre Therapeutics, Inc.股票出现异动，股价急速下挫7.45%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.60%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家商业阶段的制药公司，开发和商业化针对器官疾病的小分子抗炎和抗纤维化药物，特别关注器官纤维化。该公司的可报告部门是 Gyre Pharmaceuticals，该公司从在中国销售 艾思瑞和某些仿制药、Gyre 和其他部门获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409213144aa2c6479&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409213144aa2c6479&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GYRE","BK4007","LENZ"],"gpt_icon":0},{"id":"2525049823","title":"Gyre Therapeutics, Inc.盤中異動 股價大跌6.01%報6.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525049823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525049823?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 21:38","pubTimestamp":1744033103,"startTime":"0","endTime":"0","summary":"北京时间2025年04月07日21时38分，Gyre Therapeutics, Inc.股票出现异动，股价快速跳水6.01%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.71%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家商业阶段的制药公司，开发和商业化针对器官疾病的小分子抗炎和抗纤维化药物，特别关注器官纤维化。该公司的可报告部门是 Gyre Pharmaceuticals，该公司从在中国销售 艾思瑞和某些仿制药、Gyre 和其他部门获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040721382494ce51c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040721382494ce51c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2524994786","title":"Gyre Therapeutics, Inc.盤中異動 早盤大幅下挫5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524994786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524994786?lang=zh_tw&edition=fundamental","pubTime":"2025-04-04 22:34","pubTimestamp":1743777253,"startTime":"0","endTime":"0","summary":"北京时间2025年04月04日22时34分，Gyre Therapeutics, Inc.股票出现波动，股价急速下跌5.15%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.31%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家商业阶段的制药公司，开发和商业化针对器官疾病的小分子抗炎和抗纤维化药物，特别关注器官纤维化。该公司的可报告部门是 Gyre Pharmaceuticals，该公司从在中国销售 艾思瑞和某些仿制药、Gyre 和其他部门获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404223414972e83a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404223414972e83a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","BK4139","LENZ"],"gpt_icon":0},{"id":"2524500782","title":"Gyre Therapeutics, Inc.盤中異動 早盤快速下跌6.77%報6.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524500782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524500782?lang=zh_tw&edition=fundamental","pubTime":"2025-04-03 21:30","pubTimestamp":1743687026,"startTime":"0","endTime":"0","summary":"北京时间2025年04月03日21时30分，Gyre Therapeutics, Inc.股票出现异动，股价快速下挫6.77%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家商业阶段的制药公司，开发和商业化针对器官疾病的小分子抗炎和抗纤维化药物，特别关注器官纤维化。该公司的可报告部门是 Gyre Pharmaceuticals，该公司从在中国销售 艾思瑞和某些仿制药、Gyre 和其他部门获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403213026a44cba18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403213026a44cba18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","GYRE"],"gpt_icon":0},{"id":"2520129511","title":"Gyre Therapeutics, Inc.2024財年實現淨利潤12.09百萬美元，同比增加113.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2520129511","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520129511?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 10:00","pubTimestamp":1742436029,"startTime":"0","endTime":"0","summary":"3月20日，Gyre Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为12.09百万美元，同比增加113.01%；其中营业收入为1.06亿美元，同比减少6.19%，每股基本收益为0.14美元。从资产负债表来看，Gyre Therapeutics, Inc.总负债27.00百万美元，其中短期债务713000.00美元，资产负债比为0.05，流动比率为3.32。机构评级：截至2025年3月20日，当前有1家机构对Gyre Therapeutics, Inc.目标价做出预测，其中目标均价为20.00美元，其中最低目标价为20.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250320100036a69cd335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250320100036a69cd335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GYRE"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GYRE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-09","symbol":"GYRE","fiscalQuarterEnding":"2025/03","expectedEps":0.03,"name":null,"time":"盤前","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":0},{"market":"US","date":"2025-03-17","symbol":"GYRE","fiscalQuarterEnding":"2024/12","expectedEps":0.04,"name":null,"time":"盤後","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"post","actualEps":0.01},{"date":"2025-02-18","symbol":"GYRE","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739869200000,"name":null,"time":"盤前","dateTimestamp":1739854800000,"actualEps":null},{"market":"US","date":"2024-11-13","symbol":"GYRE","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":0.02},{"market":"US","date":"2024-08-13","symbol":"GYRE","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":0.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GYRE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GYRE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1741752000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GYRE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GYRE","date":"2025-06-20","current":104.146938,"percent":0.930556,"low":-11548.718266,"twenty":-27.795567,"median":-12.087508,"eighty":59.335648,"high":139.727206,"avg":-1177.195588,"sd":3116.830114,"marketCap":755169444},"quantilePoints":[{"date":"2024-04-05","current":-15.607876,"twenty":-15.830217,"median":-15.617068,"eighty":-15.398378,"marketCap":1450486717},{"date":"2024-04-12","current":-31.76291,"twenty":-32.589325,"median":-21.429161,"eighty":-15.61523,"marketCap":1405212396},{"date":"2024-04-19","current":-29.754799,"twenty":-32.477335,"median":-30.585076,"eighty":-15.742078,"marketCap":1316372220},{"date":"2024-04-26","current":-31.531205,"twenty":-31.948274,"median":-30.797472,"eighty":-16.000876,"marketCap":1394961607},{"date":"2024-05-03","current":-27.239192,"twenty":-31.948274,"median":-30.778163,"eighty":-24.631989,"marketCap":1205080075},{"date":"2024-05-10","current":-14.851474,"twenty":-31.774495,"median":-30.223912,"eighty":-24.631989,"marketCap":1301657414},{"date":"2024-05-17","current":-14.909982,"twenty":-31.744918,"median":-29.754799,"eighty":-15.561911,"marketCap":1306785414},{"date":"2024-05-24","current":-12.302842,"twenty":-31.573048,"median":-28.630129,"eighty":-14.89828,"marketCap":1078282562},{"date":"2024-05-31","current":-8605.737804,"twenty":-32.075712,"median":-29.501562,"eighty":-15.108912,"marketCap":890160307},{"date":"2024-06-07","current":-8895.075775,"twenty":-32.90985,"median":-30.136978,"eighty":-15.311743,"marketCap":920088848},{"date":"2024-06-14","current":-9126.546144,"twenty":-8519.763095,"median":-30.585076,"eighty":-15.366351,"marketCap":944031680},{"date":"2024-06-21","current":-8961.210165,"twenty":-8885.155616,"median":-30.816781,"eighty":-15.424018,"marketCap":926929657},{"date":"2024-06-28","current":-8175.864257,"twenty":-8865.315298,"median":-30.894016,"eighty":-15.515947,"marketCap":845695047},{"date":"2024-07-05","current":-9688.68848,"twenty":-8961.210165,"median":-31.531205,"eighty":-15.611553,"marketCap":1002178559},{"date":"2024-07-12","current":-10424.433593,"twenty":-9151.346542,"median":-31.791873,"eighty":-15.679573,"marketCap":1078282562},{"date":"2024-07-15","current":-11094.044316,"twenty":-9210.867496,"median":-31.820836,"eighty":-15.710825,"marketCap":1147545756},{"date":"2024-08-02","current":-11548.718266,"twenty":-9298.495565,"median":-32.139431,"eighty":-15.742078,"marketCap":1194576320},{"date":"2024-08-09","current":-8374.267436,"twenty":-9189.373818,"median":-32.728348,"eighty":-16.000876,"marketCap":866217475},{"date":"2024-08-16","current":-10.635127,"twenty":-9134.812943,"median":-32.641458,"eighty":-15.61523,"marketCap":914301855},{"date":"2024-08-23","current":-11.421808,"twenty":-9126.546144,"median":-31.820836,"eighty":-15.175222,"marketCap":981932798},{"date":"2024-08-30","current":-13.672312,"twenty":-9020.73112,"median":-31.635813,"eighty":-14.375603,"marketCap":1175408659},{"date":"2024-09-06","current":-11.770337,"twenty":-8974.437045,"median":-30.942288,"eighty":-13.816505,"marketCap":1011895874},{"date":"2024-09-13","current":-14.920484,"twenty":-8961.210165,"median":-30.778163,"eighty":-13.696211,"marketCap":1282714046},{"date":"2024-09-20","current":-15.572509,"twenty":-8941.369845,"median":-30.223912,"eighty":-13.816505,"marketCap":1338768556},{"date":"2024-09-27","current":-13.909847,"twenty":-8923.182886,"median":-29.754799,"eighty":-13.90034,"marketCap":1195829555},{"date":"2024-10-04","current":-13.312158,"twenty":-8919.876167,"median":-28.630129,"eighty":-13.654308,"marketCap":1144446254},{"date":"2024-10-11","current":-12.327984,"twenty":-8904.995932,"median":-26.800559,"eighty":-13.325198,"marketCap":1059836795},{"date":"2024-10-18","current":-15.235629,"twenty":-8865.315298,"median":-15.915547,"eighty":-13.300875,"marketCap":1309807059},{"date":"2024-10-25","current":-15.300832,"twenty":-8830.594739,"median":-15.607876,"eighty":-13.325198,"marketCap":1315412510},{"date":"2024-10-31","current":-15.985457,"twenty":-8804.140979,"median":-15.617068,"eighty":-13.405529,"marketCap":1374269746},{"date":"2024-11-08","current":-16.365804,"twenty":-8779.340581,"median":-15.748988,"eighty":-13.558712,"marketCap":1406968211},{"date":"2024-11-15","current":-13.372591,"twenty":-8709.89947,"median":-15.77333,"eighty":-13.558712,"marketCap":1187780244},{"date":"2024-11-22","current":-11.353175,"twenty":-8602.431085,"median":-15.627389,"eighty":-13.295234,"marketCap":1008411696},{"date":"2024-11-29","current":-12.087508,"twenty":-8556.137012,"median":-15.590193,"eighty":-13.126615,"marketCap":1073636622},{"date":"2024-12-06","current":-10.111572,"twenty":-8387.494312,"median":-15.378053,"eighty":-12.781935,"marketCap":898130076},{"date":"2024-12-13","current":-9.449706,"twenty":-8374.267436,"median":-15.329691,"eighty":-12.475931,"marketCap":839341820},{"date":"2024-12-20","current":-10.299987,"twenty":-8344.506959,"median":-15.279098,"eighty":-12.329976,"marketCap":914865419},{"date":"2024-12-27","current":-12.686569,"twenty":-8225.465052,"median":-15.246496,"eighty":-12.302842,"marketCap":1126846431},{"date":"2025-01-03","current":-11.594732,"twenty":-8192.397854,"median":-15.235629,"eighty":-12.152426,"marketCap":1029867264},{"date":"2025-01-10","current":-9.29511,"twenty":-8179.170976,"median":-15.105225,"eighty":-11.98162,"marketCap":825610256},{"date":"2025-01-17","current":-10.435259,"twenty":-3290.168076,"median":-14.953086,"eighty":-11.68749,"marketCap":926880537},{"date":"2025-01-24","current":-10.242013,"twenty":-32.95233,"median":-14.893499,"eighty":-11.536758,"marketCap":909716083},{"date":"2025-01-31","current":-11.111618,"twenty":-32.786274,"median":-14.681409,"eighty":-11.380628,"marketCap":986956128},{"date":"2025-02-07","current":-12.319402,"twenty":-32.658836,"median":-14.539395,"eighty":-11.347378,"marketCap":1094233968},{"date":"2025-02-14","current":-11.382162,"twenty":-32.515952,"median":-14.451664,"eighty":-11.279742,"marketCap":1010986364},{"date":"2025-02-21","current":-12.135819,"twenty":-32.330588,"median":-14.072853,"eighty":-11.345445,"marketCap":1077927736},{"date":"2025-02-28","current":-10.90871,"twenty":-31.809251,"median":-13.976035,"eighty":-11.179254,"marketCap":968933450},{"date":"2025-03-07","current":-10.338636,"twenty":-31.758412,"median":-13.909847,"eighty":-11.12128,"marketCap":918298310},{"date":"2025-03-14","current":-11.556083,"twenty":-31.698577,"median":-13.789262,"eighty":-11.11355,"marketCap":1026434373},{"date":"2025-03-21","current":79.165838,"twenty":-31.423076,"median":-13.627303,"eighty":-11.045914,"marketCap":956719157},{"date":"2025-03-28","current":70.412668,"twenty":-30.971251,"median":-13.353241,"eighty":-10.90871,"marketCap":850937097},{"date":"2025-04-04","current":52.673943,"twenty":-30.878569,"median":-13.283951,"eighty":-10.748316,"marketCap":636564605},{"date":"2025-04-11","current":56.469566,"twenty":-30.809057,"median":-13.129602,"eighty":-10.622099,"marketCap":682434702},{"date":"2025-04-17","current":61.504575,"twenty":-30.778163,"median":-12.849861,"eighty":-10.560868,"marketCap":743282789},{"date":"2025-04-25","current":70.645053,"twenty":-30.585076,"median":-12.780906,"eighty":-10.377285,"marketCap":853745471},{"date":"2025-05-02","current":72.449806,"twenty":-30.310846,"median":-12.626921,"eighty":-10.338636,"marketCap":875555902},{"date":"2025-05-09","current":73.535777,"twenty":-30.136978,"median":-12.473999,"eighty":-10.164715,"marketCap":888679866},{"date":"2025-05-16","current":132.923099,"twenty":-29.947887,"median":-12.417259,"eighty":-9.938068,"marketCap":963825388},{"date":"2025-05-23","current":136.20365,"twenty":-29.754799,"median":-12.327984,"eighty":-9.652614,"marketCap":987612669},{"date":"2025-05-30","current":117.840031,"twenty":-29.349619,"median":-12.308068,"eighty":-9.440044,"marketCap":854458067},{"date":"2025-06-06","current":99.64599,"twenty":-28.753768,"median":-12.251767,"eighty":50.257139,"marketCap":722533070},{"date":"2025-06-13","current":100.896253,"twenty":-28.630129,"median":-12.168656,"eighty":56.159719,"marketCap":731598729},{"date":"2025-06-20","current":104.146938,"twenty":-27.795567,"median":-12.087508,"eighty":59.335648,"marketCap":755169444}],"updateTime":1750685770026}}}